Monopar Therapeutics Inc (MNPR) — Financial Flexibility Index
Monopar Therapeutics Inc (MNPR) has a Financial Flexibility Index of 0.00x as of December 2025. Free cash flow of $-3.37 Million (operating CF $-3.37 Million minus capex $0.00) represents 0% of total liabilities ($2.89 Billion). Also explore Monopar Therapeutics Inc (MNPR) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Monopar Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Monopar Therapeutics Inc across 11 annual periods. Check Monopar Therapeutics Inc (MNPR) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Monopar Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Monopar Therapeutics Inc. For the full company profile including market capitalisation, see Monopar Therapeutics Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.22x | $-12.20 Billion | $-12.20 Billion | $2.89 Billion | ▼ -246.4% |
| 2024 | -1.22x | $-6.40 Million | $-6.40 Million | $5.25 Million | ▲ +72.7% |
| 2023 | -4.47x | $-7.86 Million | $-7.86 Million | $1.76 Million | ▼ -94.1% |
| 2022 | -2.30x | $-7.23 Million | $-7.23 Million | $3.14 Million | ▲ +50.2% |
| 2021 | -4.63x | $-7.32 Million | $-7.32 Million | $1.58 Million | ▼ -16.8% |
| 2020 | -3.96x | $-4.66 Million | $-4.66 Million | $1.18 Million | ▲ +4.9% |
| 2019 | -4.17x | $-3.02 Million | $-3.02 Million | $724.16K | ▲ +42.3% |
| 2018 | -7.23x | $-2.89 Million | $-2.89 Million | $399.55K | ▲ +14.2% |
| 2017 | -8.42x | $-2.63 Million | $-2.63 Million | $311.87K | ▲ +54.5% |
| 2016 | -18.52x | $-1.19 Million | $-1.19 Million | $64.51K | ▼ -114.9% |
| 2015 | -8.62x | $-636.33K | $-636.33K | $73.84K | — |